Serum end point titre distribution of anti-human S-antigen antibodies in patients with TR, IRV, and normal healthy controls by ELISA
| End point titres >400 | End point titres ⩾3200 | |
|---|---|---|
| Toxoplasma retinochoroiditis | 27/36 (75%) | 11/36 (31%) |
| Idiopathic retinal vasculitis | 9/12 (75%) | 5/12 (42%) |
| Healthy controls | 10/16 (63%) | 5/16 (31%) |